Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer to consider stockpiling medicines in preperation for no-deal Brexit

August 6, 2018
Sales and Marketing EU, MSD, Pfizer, Sanofi, brexit, stockpiling

Pfizer is considering joining AstraZeneca, Sanofi and MSD in stockpiling medicines in preparation for a hard Brexit, it has emerged. …

News
armind_madan

England’s top GP resigns over imflammatory online comments

August 6, 2018
Medical Communications, Research and Development, Sales and Marketing Dr Armind Madan, England, GP, pharma

England’s most senior General Practitioner and Director of Primary Care and Deputy Medical Director at NHS England has resigned over …

News
16193381408_003eb2fdc9_z1

Irish trade lobby warns EU amendments could threaten pharma industry in Ireland, critics contest

August 6, 2018
Sales and Marketing EU, IPHA, Ireland, biosimilars, generics, intellectual property, trade lobby

The Irish Pharmaceutical Healthcare Association (IPHA) has warned that changes to existing intellectual property legislation could threaten innovation and deter …

News

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation

August 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, pharma, signet chemical corporation

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for …

News
Press release
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, GSK, Sanofi, brexit, pharmafile, top 10

While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …

News
allergan

Almirall picks up Allergan’s dermatology portfolio to for $650m

August 3, 2018
Medical Communications, Sales and Marketing Allergan, Almirall, dermatology, pharma

Allergan has sealed a deal to sell its dermatology portfolio, comprising five brands, to Spanish pharmaceutical firm Almirall for $650 …

News
shutterstock_212035546

Epizyme shuts down failing lymphoma trial as FDA imposes clinical hold

August 3, 2018
Medical Communications, Research and Development Epizyme, FDA, lymphoma, pharma, tazemetostat

Epizyme’s Q2 financial results have been derailed by the company’s decision to terminate further Phase 2 development of its lead …

News

Allergan sues Pfizer over opioid crisis lawsuits

August 3, 2018
Medical Communications Allergan, Litigation, Pfizer, lawsuits, opioid crisis, opioids

Allergan are suing American pharma giant Pfizer over potential damages that they may be forced to pay relating to hundreds …

News

Computer simulations predict spread of HIV

August 3, 2018
Medical Communications

Researchers at the Los Alamos National Laboratory have developed a computer simulation that is able to accurately predict the transmission …

News
usmarinetankinbaghdad

Lawsuit alleges pharma giants funded terror in Iraq

August 2, 2018
Business Services, Medical Communications, Sales and Marketing AstraZeneca, Iraq War, J&J, JJ, Litigation, Roche, corruption, terrorism

The United States Justice Department is investigating claims that major pharmaceutical and medical device companies were aware that supplies that …

News

Novartis hands over global rights for two oncology drugs to Shanghai’s Laekna

August 2, 2018
Sales and Marketing Cancer, Laekna, Novartis, oncology, pharma

Novartis has revealed that it has jettisoned two of its clinical stage oncology products along with exclusive global development and …

News
shutterstock_38078521

Two injured in chemical incident at Sanofi lab in Ireland

August 2, 2018
Manufacturing and Production Ireland, Sanofi, pharma

Two female employees have been injured in a chemical incident at a Sanofi lab at the company’s Waterford site in …

News
ema_logo

EMA to cut activities as it forecasts loss of 30% of staff

August 2, 2018
Medical Communications, Research and Development EMA, London, UK, amsterdam, brexit, disruption, staff

The European Medicines Agency is set to enact temporary cuts in activities as it prepares for significant disruption in the …

News
rowa_vmax

Biosimilars and generics saved NHS £324m last year

August 2, 2018
Medical Communications, Sales and Marketing Cancer, NHS, biosimilars, funding, generics

The NHS watchdog, NHS Improvement, has revealed that the British National Health Service saved £324 million last financial year by …

News

Sanofi join AstraZeneca and MSD in stockpiling medicines, 1800 jobs at risk

August 1, 2018
Research and Development Jobs, Sanofi, brexit, manufacturing, stockpiling

French multinational Sanofi have begun stockpiling drugs in preparation for a no-deal Brexit. The company will join AstraZeneca and MSD …

News
otsuka_web

Otsuka scores EU schizophrenia approval, but acute myeloid leukaemia drug flops at Phase 3

August 1, 2018
Research and Development, Sales and Marketing Astex, Otsuka, Rxulti, guadecitabine, pharma, schizophrenia

It’s bittersweet news for Otsuka as it emerges that the European Commission saw fit to approve its therapy Rxulti (brexpiprazole) …

News

Parents demonstrate in response to Chinese vaccine scandal

August 1, 2018

Concerned parents have begun demonstrating in Beijing in response to the Changsheng Biotechnology vaccine scandal. More than two dozen protestors …

News

Pfizer notches two EU approvals, including Herceptin biosimilar

August 1, 2018
Research and Development, Sales and Marketing Cancer, EMA, EU, Genetech, Herceptin, Pfizer, Trazimera, Xeljanz, biosimilar, breast cancer, pharma

Pfizer is patting itself on the back after securing two new approvals in Europe within 24 hours: Xeljanz (tofacitinib citrate) …

News
ianread

Pharma CEO Ian Read forcasts rebate-free drug market

August 1, 2018
Research and Development CEO, Ian Read, PBMs, Pfizer, Rebates

The CEO of American multinational Pfizer has said that he believes the Trump administration will eliminate rebates on prescription drug …

News
US regulators FDA building

FDA rejects Insys Therapeutics sublingual opioid spray

July 31, 2018
Manufacturing and Production Crisis, FDA, insys, opioid, rejection, spray

The FDA has rejected Insys Therapeutics buprenorphine sublingual spray due to concerns about the safety of the Arizona-based company’s opioid …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026